Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells
Yun Yu, Tao Wu, Xiaodong Zhang, Pengfei Li, Lihua Ye, Jiayang Kuang, Tao Lu, Lianli Ni, Qi Zhao, Ji Zhang, Huanle Pan, Congying Xie, Chenguo Zheng, Shaotang Li, Ri Cui, Ri Cui
Topics & Concepts
RegorafenibOxaliplatinColorectal cancerMedicineCancer researchPharmacologyOxidative stressTolerabilityCancerInternal medicineAdverse effectMetal complexes synthesis and propertiesGenomics, phytochemicals, and oxidative stressGlutathione Transferases and Polymorphisms